Clinical Trial Update: Survivorship Post-HCT Optimization Program [NA]

View source ↗

Summary

Clinical trial update reports the completion of Duke University’s Survivorship Post-HCT Optimization Program trial. The study targets patients with hematologic …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hematologic Malignancies

Snippet

Sponsor: Duke University | Conditions: Hematologic Malignancy | NA | Status: COMPLETED